ABOUT US
The Founding Warriors
OUR STORY
It’s been said that the best ideas are born out of necessity. That’s how our organization got its start. Thymic Carcinoma Center (TCC) was founded for patients by patients desperate for hope and information at a time when both were almost non-existent. They believed there had to be something better than what is currently available to patients and caregivers. It was their mission to find it. They couldn’t find it, so they created it. The warriors we call “The Original 4” are pictured below. They laid the foundation in 2015, and TCC became a nationally recognized 501(c)(3) nonprofit organization in March 2021. We are already realizing our vision of helping patients and caregivers live longer, healthier, happier lives.
Board of Directors
Michael Delaney
President & Co-Founder
Thymic Carcinoma Center
Joseph W. Carter lll
President/CEO
Industrial Warehousing of North America, LLC
Adam Davidson
President/CEO
Davidson Homes, LLC
Giuseppe Giaccone
Professor of Medicine, Weill-Cornell Medicine, New York.
Julie Jaklevic
Legal Assistant
Wallace Kolich & Slocum
Justine Kane
Sr. Event Manager
Marriott International/Thymic Carcinoma Center
Genny Kiley
Senior Corporate Counsel
Weyerhaeuser
David Low
Partner
MTS Health Partners LP
Michael Zeidman
Retired Independent Broker & Trader
CMEGroup-Chicago
Officers
David Low
Chairman
Giuseppe Giaccone
Vice Chairman
Michael Delaney
Treasurer
Julie Jaklevic
Secretary
Scientific Review Board
Dr. Giuseppe Giaccone
Chair of SRB
Board Member of TCC
Dr. Chul Kim – Associate Professor, Thoracic Medical Oncologist
Georgetown University Hospital
Washington DC
Dr. Giuseppe Giaccone – Professor Medical Oncologist and Lab Researcher
Weill-Cornell Medicine
New York, NY
Dr. Marina Garassino -Professor of Medicine Director of Hematology/Oncology
University of Chicago
Chicago, IL
Dr. Chris Nabel – Medical Oncologist and instructor at Harvard Medical School
Massachusetts General Hospital,
Boston, MA
Dr. David Kwiatkowski – Professor of Medicine and Senior Physician
Brigham and Women’s Hospital/Dana Farber Cancer Institute
Boston, MA
Dr. Ignatio Wistuba – Professor and Chair, Department of Translational Molecular Pathology
The University of Texas MD Anderson Cancer Center
Houston, TX
BLOGS
Coming Soon
PODCAST
Coming Soon